BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial.
Wang W, He S, Zhang W, Zhang H, DeStefano VM, Wada M, Pinz K, Deener G, Shah D, Hagag N, Wang M, Hong M, Zeng R, Lan T, Ma Y, Li F, Liang Y, Guo Z, Zou C, Wang M, Ding L, Ma Y, Yuan Y.
Wang W, et al. Among authors: liang y.
Ann Rheum Dis. 2024 May 22:ard-2024-225785. doi: 10.1136/ard-2024-225785. Online ahead of print.
Ann Rheum Dis. 2024.
PMID: 38777376